vs

Side-by-side financial comparison of BREAD FINANCIAL HOLDINGS, INC. (BFH) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $975.0M, roughly 1.5× BREAD FINANCIAL HOLDINGS, INC.). On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 5.4%). Over the past eight quarters, ResMed's revenue compounded faster (7.9% CAGR vs -0.8%).

Bread Financial Holdings, Inc. is an American publicly traded provider of private label credit cards, coalition loyalty programs, and direct marketing, derived from the capture and analysis of transaction-rich data.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

BFH vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.5× larger
RMD
$1.4B
$975.0M
BFH
Growing faster (revenue YoY)
RMD
RMD
+5.6% gap
RMD
11.0%
5.4%
BFH
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.9%
-0.8%
BFH

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
BFH
BFH
RMD
RMD
Revenue
$975.0M
$1.4B
Net Profit
$392.6M
Gross Margin
61.8%
Operating Margin
4.9%
34.6%
Net Margin
27.6%
Revenue YoY
5.4%
11.0%
Net Profit YoY
13.9%
EPS (diluted)
$1.21
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BFH
BFH
RMD
RMD
Q2 26
$1.4B
Q4 25
$975.0M
$1.4B
Q3 25
$971.0M
$1.3B
Q2 25
$929.0M
$1.3B
Q1 25
$970.0M
$1.3B
Q4 24
$925.0M
$1.3B
Q3 24
$983.0M
$1.2B
Q2 24
$939.0M
$1.2B
Net Profit
BFH
BFH
RMD
RMD
Q2 26
$392.6M
Q4 25
$392.6M
Q3 25
$188.0M
$348.5M
Q2 25
$139.0M
$379.7M
Q1 25
$138.0M
$365.0M
Q4 24
$344.6M
Q3 24
$2.0M
$311.4M
Q2 24
$133.0M
$292.2M
Gross Margin
BFH
BFH
RMD
RMD
Q2 26
61.8%
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Q2 24
58.5%
Operating Margin
BFH
BFH
RMD
RMD
Q2 26
34.6%
Q4 25
4.9%
34.6%
Q3 25
20.2%
33.4%
Q2 25
18.7%
33.7%
Q1 25
20.3%
33.0%
Q4 24
-2.9%
32.5%
Q3 24
4.1%
31.6%
Q2 24
19.2%
31.2%
Net Margin
BFH
BFH
RMD
RMD
Q2 26
27.6%
Q4 25
27.6%
Q3 25
19.4%
26.1%
Q2 25
15.0%
28.2%
Q1 25
14.2%
28.3%
Q4 24
26.9%
Q3 24
0.2%
25.4%
Q2 24
14.2%
23.9%
EPS (diluted)
BFH
BFH
RMD
RMD
Q2 26
$2.68
Q4 25
$1.21
$2.68
Q3 25
$3.96
$2.37
Q2 25
$2.94
$2.58
Q1 25
$2.78
$2.48
Q4 24
$0.08
$2.34
Q3 24
$0.05
$2.11
Q2 24
$2.66
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BFH
BFH
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$3.6B
$1.4B
Total DebtLower is stronger
$4.3B
$663.8M
Stockholders' EquityBook value
$3.3B
$6.3B
Total Assets
$22.7B
$8.5B
Debt / EquityLower = less leverage
1.29×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BFH
BFH
RMD
RMD
Q2 26
$1.4B
Q4 25
$3.6B
$1.4B
Q3 25
$3.8B
$1.4B
Q2 25
$3.8B
$1.2B
Q1 25
$4.2B
$932.7M
Q4 24
$4.0B
$521.9M
Q3 24
$3.5B
$426.4M
Q2 24
$4.1B
$238.4M
Total Debt
BFH
BFH
RMD
RMD
Q2 26
$663.8M
Q4 25
$4.3B
$403.9M
Q3 25
$3.8B
$408.7M
Q2 25
$4.2B
$658.4M
Q1 25
$5.1B
$663.1M
Q4 24
$5.6B
$662.9M
Q3 24
$4.6B
$667.6M
Q2 24
$697.3M
Stockholders' Equity
BFH
BFH
RMD
RMD
Q2 26
$6.3B
Q4 25
$3.3B
$6.3B
Q3 25
$3.3B
$6.1B
Q2 25
$3.2B
$6.0B
Q1 25
$3.1B
$5.5B
Q4 24
$3.1B
$5.3B
Q3 24
$3.1B
$5.2B
Q2 24
$3.2B
$4.9B
Total Assets
BFH
BFH
RMD
RMD
Q2 26
$8.5B
Q4 25
$22.7B
$8.5B
Q3 25
$21.7B
$8.3B
Q2 25
$21.8B
$8.2B
Q1 25
$22.4B
$7.6B
Q4 24
$22.9B
$7.1B
Q3 24
$21.7B
$7.2B
Q2 24
$22.1B
$6.9B
Debt / Equity
BFH
BFH
RMD
RMD
Q2 26
0.11×
Q4 25
1.29×
0.06×
Q3 25
1.14×
0.07×
Q2 25
1.34×
0.11×
Q1 25
1.67×
0.12×
Q4 24
1.82×
0.13×
Q3 24
1.47×
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BFH
BFH
RMD
RMD
Operating Cash FlowLast quarter
$568.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BFH
BFH
RMD
RMD
Q2 26
Q4 25
$568.0M
$339.7M
Q3 25
$605.0M
$457.3M
Q2 25
$526.0M
$538.8M
Q1 25
$393.0M
$578.7M
Q4 24
$479.0M
$308.6M
Q3 24
$456.0M
$325.5M
Q2 24
$477.0M
$440.1M
Free Cash Flow
BFH
BFH
RMD
RMD
Q2 26
Q4 25
$311.2M
Q3 25
$414.4M
Q2 25
$508.2M
Q1 25
$557.9M
Q4 24
$288.0M
Q3 24
$307.7M
Q2 24
$415.2M
FCF Margin
BFH
BFH
RMD
RMD
Q2 26
Q4 25
21.9%
Q3 25
31.0%
Q2 25
37.7%
Q1 25
43.2%
Q4 24
22.5%
Q3 24
25.1%
Q2 24
33.9%
Capex Intensity
BFH
BFH
RMD
RMD
Q2 26
Q4 25
2.0%
Q3 25
3.2%
Q2 25
2.3%
Q1 25
1.6%
Q4 24
1.6%
Q3 24
1.5%
Q2 24
2.0%
Cash Conversion
BFH
BFH
RMD
RMD
Q2 26
Q4 25
0.87×
Q3 25
3.22×
1.31×
Q2 25
3.78×
1.42×
Q1 25
2.85×
1.59×
Q4 24
0.90×
Q3 24
228.00×
1.05×
Q2 24
3.59×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons